-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Galectin Therapeutics Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2024.
- Galectin Therapeutics Inc Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $591K, a 18.9% increase year-over-year.
- Galectin Therapeutics Inc Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $2.45M, a 8.23% increase year-over-year.
- Galectin Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2024 was $2.45M, a 8.23% increase from 2023.
- Galectin Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2023 was $2.26M, a 21.1% decline from 2022.
- Galectin Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2022 was $2.87M, a 38.1% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)